International Rare Cancers Initiative

被引：39

作者：

Keat, Nicola ^{[1
]}

Law, Kate ^{[1
]}

Seymour, Matthew ^{[2
]}

Welch, Jack ^{[3
]}

Trimble, Ted ^{[4
]}

Lascombe, Denis ^{[5
]}

Negrouk, Anastassia ^{[5
]}

机构：

[1] Canc Res UK, London EC1V 4AD, England

[2] Univ Leeds, NCRN, Leeds, W Yorkshire, England

[3] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA

[4] NCI, Ctr Global Hlth, Bethesda, MD 20892 USA

[5] European Org Res Treatment Canc, Brussels, Belgium

来源：

LANCET ONCOLOGY | 2013年 / 14卷 / 02期

关键词：

D O I：

10.1016/S1470-2045(12)70570-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：109 / 110

页数：3

共 50 条

[21] International Childbirth Initiative
Tolson, Debra
INTERNATIONAL JOURNAL OF CHILDBIRTH EDUCATION, 2018, 33 (03): : 5 - 5
[22] RARE CANCERS, NO RARE SOLUTIONS: RISK SHARING ARRANGEMNTS TO REIMBURSE MEDICINES FOR RARE CANCERS IN AUSTRALIA
Tuffaha, H.
Scuffham, P.
VALUE IN HEALTH, 2018, 21 : S110 - S110
[23] RARE CANCERS IN EUROPE
Gatta, G.
Trama, A.
van Der Zwan, J. M.
Mallone, S.
Capocaccia, R.
Licitra, L.
Dei Tos, A. P.
Siesling, S.
Otter, R.
Casali, P. G.
ANNALS OF ONCOLOGY, 2010, 21 : 339 - 339
[24] Rare Cancers Preface
Eslick, Guy D.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (06) : XI - XII
[25] Rare uterine cancers
Acharya, S
Hensley, ML
Montag, AC
Fleming, GF
LANCET ONCOLOGY, 2005, 6 (12): : 961 - 971
[26] Treatment for rare cancers
St Guily, J. Lacau
Rheims, N.
ONCOLOGIE, 2008, 10 (06) : 359 - 359
[27] Immunotherapies in rare cancers
Vivekanandhan, Sneha
Bahr, Deborah
Kothari, Ashish
Ashary, Mohammed Ali
Baksh, Mizba
Gabriel, Emmanuel
MOLECULAR CANCER, 2023, 22 (01)
[28] Immunotherapies in rare cancers
Sneha Vivekanandhan
Deborah Bahr
Ashish Kothari
Mohammed Ali Ashary
Mizba Baksh
Emmanuel Gabriel
Molecular Cancer, 22
[29] Reassessing rare cancers
Olver, Ian N.
MEDICAL JOURNAL OF AUSTRALIA, 2015, 203 (10) : 1 - +
[30] Immunotherapy in rare cancers
Koyyala, Venkata Pradeep Babu
Kulkarni, Padmaj
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (06) : 801 - 803